GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Intellia Therapeutics NTLA · USD

Health Care · US listing · 🇺🇸 United States

Compare

12.11

+6.70%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

25 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 10Buy
  • 7Hold
  • 3Sell
  • 1Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 12.11Average target 23.40

Low
9.00
Average
23.40
Median
20.50
High
49.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029
Revenue$50.3m$121.2m$356.7m$965.1m
Revenue, highest$91.2m$512.6m$2.15bn$4.69bn
Revenue, lowest$20.7m$6.6m$32.4m$130.9m
Earnings per share-3.20-2.63-1.661.10
Earnings per share, highest-2.831.105.886.62
Earnings per share, lowest-3.47-3.79-3.93-0.14
Analysts13131210

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast-0.80-0.92-0.97-1.02-1.04-1.31-1.36-1.41
Reported-0.80-0.81-0.83-0.92-0.98-1.10-1.27-1.34
Difference-0.1%+12.0%+14.8%+10.0%+5.6%+15.9%+6.3%+5.1%

Rating changes

Latest broker notes

  • Evercore ISI GroupIn Line → Outperform
  • Wolfe ResearchPeer Perform → Underperform
  • WedbushNeutral
  • Canaccord GenuityBuy
  • WedbushNeutral
  • HC Wainwright & Co.Buy
  • CitizensMarket Outperform
  • HC Wainwright & Co.Buy
  • BernsteinMarket Perform
  • WedbushNeutral
  • Canaccord GenuityBuy
  • Morgan StanleyEqual Weight

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 27.3% a year over 10 years. Return on equity -61.5%.

Model fair value

12.07

From earnings —, from revenue 12.07.

Piotroski score

3 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.